uniQure (QURE) Amortizatization of Intangibles (2023 - 2026)
uniQure's (QURE) quarterly Amortizatization of Intangibles came in at -$4.3 million in Q1 2026, down 104.77% year-on-year from $90.9 million in Q1 2025, and up 0.85% quarter-over-quarter from -$4.4 million in Q4 2025.
uniQure (QURE) Amortizatization of Intangibles (2023 - 2026) Analysis & Trends
uniQure's Amortizatization of Intangibles history runs 4 years deep, the most recent figure standing at -$4.3 million for Q1 2026.
- On a quarterly basis, Amortizatization of Intangibles fell 104.77% year-over-year to -$4.3 million in Q1 2026; TTM through Mar 2026 was -$12.7 million, a 36.02% decrease from a year earlier, with the FY2025 full-year figure at -$10.5 million, up 4.02% from the prior year.
- Amortizatization of Intangibles rose to -$4.3 million in Q1 2026 per QURE's latest filing, from -$4.4 million in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at -$912000.0 in Q2 2023 and bottomed at -$4.7 million in Q3 2023.
- The 4-year median for Amortizatization of Intangibles is -$2.4 million (2024), against an average of -$2.8 million.
- Biggest YoY gain for Amortizatization of Intangibles was 61.64% in 2024; the steepest drop was 299.46% in 2024.
- Year by year, Amortizatization of Intangibles stood at -$4.4 million in 2023, then soared by 44.64% to -$2.4 million in 2024, then plunged by 79.99% to -$4.4 million in 2025, then grew by 0.85% to -$4.3 million in 2026.
- Per Business Quant, the three latest QURE Amortizatization of Intangibles figures stand at -$4.3 million (Q1 2026), -$4.4 million (Q4 2025), and -$1.9 million (Q3 2025).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 66,621.14 Bn | 66,620.85 Bn | - | - |
| 2 | Nanobiotix | 1,915.18 Bn | 1,915.11 Bn | - | - |
| 3 | Akari Therapeutics | 1,014.18 Bn | 1,014.18 Bn | - | - |
| 4 | BeOne Medicines | 471.27 Bn | 466.48 Bn | 1.35 Bn | - |
| 5 | Vertex Pharmaceuticals | 121.81 Bn | 114.57 Bn | 2.59 Bn | - |
| 6 | Regeneron Pharmaceuticals | 69.58 Bn | 60.82 Bn | 3.31 Bn | - |
| 7 | Belite Bio | 62.72 Bn | 62.72 Bn | - | - |
| 8 | Argenx Se | 55.51 Bn | 50.33 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.35 Bn | 37.35 Bn | - | 3.22 Mn |
| 10 | uniQure | 2.41 Bn | 2.41 Bn | 3.34 Mn | -4.34 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | -4.34 Mn |
| Mar 31, 2026 | -4.34 Mn |
| Dec 31, 2025 | -4.37 Mn |
| Dec 31, 2025 | -4.37 Mn |
| Sep 30, 2025 | -1.93 Mn |
| Sep 30, 2025 | -1.93 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Jun 30, 2025 | -2.05 Mn |
| Mar 31, 2025 | -2.12 Mn |
| Mar 31, 2025 | -2.12 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Dec 31, 2024 | -2.43 Mn |
| Sep 30, 2024 | -1.80 Mn |
| Sep 30, 2024 | -1.80 Mn |
| Jun 30, 2024 | -2.98 Mn |
| Jun 30, 2024 | -2.98 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Mar 31, 2024 | -3.70 Mn |
| Dec 31, 2023 | -4.39 Mn |
| Dec 31, 2023 | -4.39 Mn |